Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 75

Sort by

Sort Order Select

Journal Articles

Chimeric Antigen Receptor T Cell Therapy Bridged to the Second Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Toxicity Conditioning for B-Cell Acute Lymphoblastic Leukemia Relapsed after the First Transplant

Yongqiang Zhao, Yanzhi Song, Zhihui Li, Feifei Li, Dongfang Yang, Rui Wang, Fang Fang, Huiyu Li, Tong Wu

Blood (2024) 144 (Supplement 1): 3544.

https://doi.org/10.1182/blood-2024-202852

Published: 2024

Journal Articles

Long-Term Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Resistant Ph+ Acute B Lymphoblastic Leukemia That Cannot Get MRD- Remission after Multi-Line Treatment

Yanzhi Song, Erhui Yuan, Qishu Qin, Qi Wang, Zhanxiang Liu, Kong Gao, Zhihui Li, Yongqiang Zhao, Tong Wu

Blood (2024) 144 (Supplement 1): 2164.

https://doi.org/10.1182/blood-2024-202388

Published: 2024

Journal Articles

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Keyan Yang, Lei Wang, Xianxuan Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 4922.

https://doi.org/10.1182/blood-2024-200716

Published: 2024

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Zhihui Li, Xianxuan Wang, Keyan Yang, Lei Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 599.

https://doi.org/10.1182/blood-2024-200684

Published: 2024

Journal Articles

The TFG-ROS1 Fusion Is an Oncogenic Driver of Human Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 38.

https://doi.org/10.1182/blood-2024-206598

Published: 2024

Journal Articles

The Safety and Efficacy of CD33 CAR-T Therapy for RR AML after HSCT

Yuehui Lin, Defeng Zhao, Biping Deng, Dan Liu, Hong Yan, Biyi Li, Yu Xia, Ruyue Zheng, Tong Wu, Chunrong Tong

Blood (2024) 144 (Supplement 1): 3467.

https://doi.org/10.1182/blood-2024-207659

Published: 2024

Journal Articles

Transcriptome Data Analysis of 80 B ALL Patients in China

Yuehui Lin, Dan Liu, Yu Xia, Yu Xia, Tong Wu, Qinlong Zheng

Blood (2024) 144 (Supplement 1): 5924.

https://doi.org/10.1182/blood-2024-209904

Published: 2024

Journal Articles

Clinical Analysis of CAR-T Cell Therapy in Patients with Relapsed Acute B-Lymphoblastic Leukemia after Second Allogeneic Hematopoietic Stem Cell Transplantation

Hong Yan, Biyi Li, Ruyue Zheng, Yuehui Lin, Lihong An, Biping Deng, Chunrong Tong, Tong Wu, Defeng Zhao

Blood (2024) 144 (Supplement 1): 7214.

https://doi.org/10.1182/blood-2024-204694

Published: 2024

Journal Articles

Clinical Analysis of Sequential CAR-T Therapy Combined with Demethylating Agents and Personalized Targeted Drugs in 18 Elderly Patients with Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Biyi Li, Hong Yan, Ruyue Zheng, Shuangyou Liu, Yuehui Lin, Lihong An, Biping Deng, Qinlong Zheng, Chunrong Tong, Tong Wu, Defeng Zhao

Blood (2024) 144 (Supplement 1): 7213.

https://doi.org/10.1182/blood-2024-204670

Published: 2024

Journal Articles

Exploratory Analysis of Biomarkers for Quality Control of Cell Cultures and Prediction of Response to CART Cell Therapy

Guoai Su, Tong Wu

Blood (2024) 144 (Supplement 1): 7271.

https://doi.org/10.1182/blood-2024-212218

Published: 2024

Journal Articles

Clinical Analysis of CAR-T Cell Therapy in Patients with Acute B-Lymphoblastic Leukemia and Central Nervous System Infiltration

Hong Yan, Biyi Li, Ruyue Zheng, Yuehui Lin, Biping Deng, Chunrong Tong, Tong Wu, Defeng Zhao

Blood (2024) 144 (Supplement 1): 7215.

https://doi.org/10.1182/blood-2024-204742

Published: 2024

Journal Articles

Clinical Analysis of 15 Cases of Extramedullary Relapse of Acute B-Lymphoblastic Leukemia Post-Transplant Treated with CART Combined with Radiotherapy

Ruyue Zheng, Hong Yan, Biyi Li, Yuehui Lin, Shuangyou Liu, Lihong An, Biping Deng, Jun Zhang, Chunrong Tong, Tong Wu, Defeng Zhao

Blood (2024) 144 (Supplement 1): 7212.

https://doi.org/10.1182/blood-2024-204574

Published: 2024

Journal Articles

The Safety and Efficacy of Inotuzumab Treatment for Elderly Unfit r/r B ALL

Yuehui Lin, Dan Liu, Yu Xia, Tong Wu, Chunrong Tong

Blood (2024) 144 (Supplement 1): 5891.

https://doi.org/10.1182/blood-2024-210481

Published: 2024

Journal Articles

Clinical Features of Myeloid Neoplasms with Germline GATA2 Mutations–a Systematic Review of Clinical Studies Retrieved through Extensive Searching

Yanzhi Song, Erhui Yuan, Zhanxiang Liu, Tong Wu

Blood (2023) 142 (Supplement 1): 6498.

https://doi.org/10.1182/blood-2023-186383

Published: 2023

Journal Articles

The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive

Yuehui Lin, Tong Wu, Dan Liu, Chunrong Tong

Blood (2023) 142 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2023-186153

Published: 2023

Journal Articles

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Zhihui Li, Qinlong Zheng, Keyan Yang, Teng Xu, Lei Wang, Xianxuan Wang, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2023) 142 (Supplement 1): 239.

https://doi.org/10.1182/blood-2023-180834

Published: 2023

Journal Articles

A Compilation of Experiences in Utilizing CAR-T Cell Therapy for Richter's Transformation

Shaomei Feng, Teng Xu, Haidi Liu, Peihao Zheng, Lixia Ma, Hui SHI, Tong Wu, Fan Yang, Kai HU, Xiaoyan Ke

Blood (2023) 142 (Supplement 1): 4638.

https://doi.org/10.1182/blood-2023-182797

Published: 2023

Journal Articles

Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia

Zhao Defeng, Tong Wu, Chunrong Tong, Lin Yuehui, Qinlong Zheng

Blood (2023) 142 (Supplement 1): 1612.

https://doi.org/10.1182/blood-2023-181512

Published: 2023

Journal Articles

Trametinib Maintenance in Patients with RAS Mutated Hematologic Malignancy Undergoing Allogeneic Haematopoietic Stem-Cell Transplantation: A Retrospective Transplant Study

Zhihui Li, Teng Xu, Xianxuan Wang, Xiaopei Wen, Lei Wang, Jingjing Wang, Tong Wu

Blood (2023) 142 (Supplement 1): 2212.

https://doi.org/10.1182/blood-2023-181425

Published: 2023

Journal Articles

Good Survival of CAR-T Cell Therapy Bridging to Allo-HSCT for Relapsed/Refractory Ph-Positive B-Cell Acute Lymphoblastic Leukemia

Zhanxiang Liu, Tong Wu, Yanzhi Song, Erhui Yuan, Qishu Qin, Qi Wang

Blood (2023) 142 (Supplement 1): 7043.

https://doi.org/10.1182/blood-2023-187988

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Chimeric Antigen Receptor T Cell Therapy Bridged to the Second Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Toxicity Conditioning for B-Cell Acute Lymphoblastic Leukemia Relapsed after the First Transplant

Long-Term Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Resistant Ph+ Acute B Lymphoblastic Leukemia That Cannot Get MRD- Remission after Multi-Line Treatment

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

The TFG-ROS1 Fusion Is an Oncogenic Driver of Human Myeloid Leukemia

The Safety and Efficacy of CD33 CAR-T Therapy for RR AML after HSCT

Transcriptome Data Analysis of 80 B ALL Patients in China

Clinical Analysis of CAR-T Cell Therapy in Patients with Relapsed Acute B-Lymphoblastic Leukemia after Second Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Analysis of Sequential CAR-T Therapy Combined with Demethylating Agents and Personalized Targeted Drugs in 18 Elderly Patients with Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Exploratory Analysis of Biomarkers for Quality Control of Cell Cultures and Prediction of Response to CART Cell Therapy

Clinical Analysis of CAR-T Cell Therapy in Patients with Acute B-Lymphoblastic Leukemia and Central Nervous System Infiltration

Clinical Analysis of 15 Cases of Extramedullary Relapse of Acute B-Lymphoblastic Leukemia Post-Transplant Treated with CART Combined with Radiotherapy

The Safety and Efficacy of Inotuzumab Treatment for Elderly Unfit r/r B ALL

Clinical Features of Myeloid Neoplasms with Germline GATA2 Mutations–a Systematic Review of Clinical Studies Retrieved through Extensive Searching

The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

A Compilation of Experiences in Utilizing CAR-T Cell Therapy for Richter's Transformation

Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia

Trametinib Maintenance in Patients with RAS Mutated Hematologic Malignancy Undergoing Allogeneic Haematopoietic Stem-Cell Transplantation: A Retrospective Transplant Study

Good Survival of CAR-T Cell Therapy Bridging to Allo-HSCT for Relapsed/Refractory Ph-Positive B-Cell Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only